S

Southern Adelaide Local Health Network | Southern Adelaide Diabetes and Endocrine Services

Research site

(Unclaimed)

Location

Southern Adelaide Diabetes and Endocrine Services Level 1, 10   Milham Street, Oaklands Park, South Australia, Australia

Site insights

Top conditions

Top treatments

Maridebart Cafraglutide

Fenofibrate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-1)

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Enrolling

Obesity

Drug: Placebo

Drug: Maridebart Cafraglutide

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. (FAME 1 EYE)

The purpose of this study is to evaluate the potential benefits of 145 mg of daily fenofibrate in adults with type 1 diabetes mellitus and pre-existi...

Enrolling

Diabetic Nephropathies

Type 1 Diabetes Mellitus

Drug: Inert lactose placebo

Drug: Fenofibrate

Trial sponsors

U

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms